0001625288-17-000006.txt : 20171206 0001625288-17-000006.hdr.sgml : 20171206 20171206172537 ACCESSION NUMBER: 0001625288-17-000006 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171206 DATE AS OF CHANGE: 20171206 EFFECTIVENESS DATE: 20171206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Intiva BioPharma Inc. CENTRAL INDEX KEY: 0001625288 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 262049376 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-300229 FILM NUMBER: 171243018 BUSINESS ADDRESS: STREET 1: 4340 E KENTUCKY AVE STREET 2: SUITE 206 CITY: GLENDALE STATE: CO ZIP: 80246 BUSINESS PHONE: 3034957583 MAIL ADDRESS: STREET 1: 4340 E KENTUCKY AVE STREET 2: SUITE 206 CITY: GLENDALE STATE: CO ZIP: 80246 FORMER COMPANY: FORMER CONFORMED NAME: Kinder Holding Corp. DATE OF NAME CHANGE: 20141114 D 1 primary_doc.xml X0708 D LIVE 0001625288 Intiva BioPharma Inc. 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO COLORADO 80246 3034957583 DELAWARE Kinder Holding Corp. Corporation true Jeffrey Friedland 4340 E Kentucky Ave Suite 206 Glendale CO COLORADO 80246 Executive Officer Director Evan Wasoff 4340 E Kentucky Ave Suite 206 Glendale CO COLORADO 80246 Executive Officer Robert Goldfarb 4340 E Kentucky Ave Suite 206 Glendale CO COLORADO 80246 Executive Officer Richard Greenberg 4340 E Kentucky Ave Suite 206 Glendale CO COLORADO 80246 Executive Officer Director Alain Bankier 4340 E Kentucky Ave Suite 206 Glendale CO COLORADO 80246 Director Pharmaceuticals Decline to Disclose 06b false 2017-11-29 false true true Equity issued to acquire Intiva BioPharma Inc. as a wholly-owned subsidiary 0 1350000 1350000 0 Estimated net worth of acquired company false 69 0 0 0 false Intiva BioPharma Inc. Evan Wasoff Evan Wasoff Chief Financial Officer 2017-12-05